Literature DB >> 6653640

Relative immunosuppressive potency of various corticosteroids measured in vitro.

E Langhoff, J Ladefoged.   

Abstract

Natural and synthetic steroids and mineralocorticoids were tested for their in vitro suppressive activity on phytohemagglutinin (PHA) stimulated lymphocytes. Three different (p less than 0.05) groups were identified. Methylprednisolone and betamethasone were very potent, dexamethasone, hydrocortisone and prednisolone were of intermediate potency, and aldosterone, prednisone and the metabolites of hydrocortisone were of low potency. In general, synthetic steroids were considerably more potent than naturally occurring compounds, but the relatively low potency of dexamethasone was unexpected. These in vitro findings rank glucocorticoid potency differently from the relative anti-inflammatory activities reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653640     DOI: 10.1007/BF00542111

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Clinical pharmacology of the anti-inflammatory steroids.

Authors:  G W LIDDLE
Journal:  Clin Pharmacol Ther       Date:  1961 Sep-Oct       Impact factor: 6.875

2.  Biologic activities of some C21 steroids and some 6 alpha-methyl C21 steroids.

Authors:  W E DULIN; L E BARNES; E M GLENN; S C LYSTER; E J COLLINS
Journal:  Metabolism       Date:  1958-07       Impact factor: 8.694

3.  Methylprednisolone suppression of proliferating and cytotoxic lymphocytes.

Authors:  J C Rosenberg; K Lysz
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

4.  [Pharmacokinetics and metabolism of desoxymethasone].

Authors:  I Hornke; F Cavagna; O Christ; H W Fehlhaber; H M Kellner; J Sandow
Journal:  Arzneimittelforschung       Date:  1980

5.  Absolute macrophage dependency of T lymphocyte activation by mitogens.

Authors:  D L Rosenstreich; J J Farrar; S Dougherty
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

6.  Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors:  S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

7.  A comparison of the effects of prednisolone and methylprednisolone on human lymphoblastoid cells.

Authors:  A W Waddell; A R Currie
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

8.  High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum.

Authors:  M D Smith
Journal:  J Chromatogr       Date:  1979-10-11

9.  Suppression of human cytotoxic lymphocytes by methylprednisolone. An immunosuppressive mechanism of action of steroids.

Authors:  J C Rosenberg; K Lysz
Journal:  Transplantation       Date:  1978-03       Impact factor: 4.939

10.  Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.

Authors:  J G Gambertoglio; F Vincenti; N J Feduska; J Birnbaum; O Salvatierra; W J Amend
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  11 in total

Review 1.  The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside.

Authors:  Jieping Hu; Qingke Chen
Journal:  Int Urol Nephrol       Date:  2016-12-16       Impact factor: 2.370

Review 2.  Review of the antenatal and postnatal use of steroids.

Authors:  Julie Bartholomew; Lajos Kovacs; Apostolos Papageorgiou
Journal:  Indian J Pediatr       Date:  2014-03-30       Impact factor: 1.967

3.  Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.

Authors:  M A Milad; E A Ludwig; S Anné; E Middleton; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

Review 4.  The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.

Authors:  P C Ng
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

5.  Increase in incorporation into lymphocytes in vitro of esterified anti-inflammatory corticosteroids.

Authors:  Y Mizushima; R Igarashi; K Hoshi; M Muramatsu; A Fujita
Journal:  Agents Actions       Date:  1986-10

6.  Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.

Authors:  M P Malter; C Frisch; J C Schoene-Bake; C Helmstaedter; K P Wandinger; W Stoecker; H Urbach; R Surges; C E Elger; A V Vincent; C G Bien
Journal:  J Neurol       Date:  2014-06-17       Impact factor: 4.849

7.  In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells.

Authors:  E Langhoff; K Olgaard
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

8.  Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men.

Authors:  E F L Dubois; M G M Derks; D H Schweitzer; A H Zwinderman; P N R Dekhuijzen; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  2004-05-19       Impact factor: 2.953

9.  Animal Model for Glucocorticoid Induced Osteoporosis: A Systematic Review from 2011 to 2021.

Authors:  Andy Xavier; Hechmi Toumi; Eric Lespessailles
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

10.  Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong.

Authors:  Loretta Yin-Chun Yam; Arthur Chun-Wing Lau; Florence Yuk-Lin Lai; Edwina Shung; Jane Chan; Vivian Wong
Journal:  J Infect       Date:  2006-03-15       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.